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Abstract
Introduction: The apolipoprotein E (APOE) ε4 allele is the main genetic risk factor for
Alzheimer’s disease (AD), accelerated cognitive aging, and hippocampal atrophy, but
its influence on the association between hippocampus atrophy and episodic-memory
decline in non-demented individuals remains unclear.
Methods: We analyzed longitudinal (two to six observations) magnetic resonance
imaging (MRI)–derived hippocampal volumes and episodicmemory from748 individu-
als (55 to 90 years at baseline, 50% female) from the European Lifebrain consortium.
Results: The change-change association for hippocampal volume andmemorywas sig-
nificant only in ε4 carriers (N=173, r=0.21, P= .007; non-carriers: N=467, r=0.073,
P = .117). The linear relationship was significantly steeper for the carriers [t(629) =
2.4, P = .013]. A similar trend toward a stronger change-change relation for carriers
was seen in a subsample withmore than two assessments.
Discussion: These findings provide evidence for a difference in hippocampus-memory
association between ε4 carriers and non-carriers, thus highlighting howgenetic factors
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modulate the translation of the AD-related pathophysiological cascade into cognitive
deficits.
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1 INTRODUCTION
The ε4 allele of the apolipoprotein E (APOE) gene is the major
genetic risk factor for late-onset Alzheimer’s disease (AD).1–3 Stud-
ies show accelerated hippocampal4 and episodic-memory5 decline in
AD patients with the APOE ε4 allele. In a study of Alzheimer’s disease
(AD) and dementia with Lewy bodies, an association between mem-
ory recall scores and hippocampal volume was restricted to APOE ε4
carriers.6 Such a change-change relation provides evidence for corre-
lated changes of hippocampus structure and memory in APOE ε4 car-
riers. The lack of an association in ε4 non-carriers was suggested to be
due to other factors beingmore relevant for the hippocampus-memory
relation in this group. This suggestion is in line with a model in which
genetic variation influences how the AD pathological changes confer
greater cognitive impairment in some individuals, that is, those with
more risk alleles.7 As such, this topic pertains to the fundamental clin-
ical and preclinical question of how various pathophysiological brain
changes translate into cognitive impairment in different individuals.
In non-demented individuals, the support for a longitudinal
hippocampus-episodic memory change-change relation is limited,8–11
but APOE ε4 has been associatedwith accelerated cognitive aging12–14
and hippocampal atrophy.15,16 Thus a differential influence of APOE ε4
on brain-cognition associations, reflecting greater phenotype-relevant
heterogeneity in non-carriers, might characterize also cognitively
normal older adults and preclinical dementia. However, no study to
date has comprehensively assessed the longitudinal interrelationships
among hippocampus atrophy, episodic-memory decline, and APOE ε4
in healthy, non-demented individuals.
Herein, we tested the hypothesis of a difference in longitu-
dinal relations between hippocampal atrophy and linear episodic
memory changes between non-demented APOE ε4 carriers and
non-carriers.
2 METHODS
2.1 Lifebrain sample
The sample was derived from the European Lifebrain project (17;
www.lifebrain.uio.no). In the present analyses, individuals from six
studies within four sites18–25 were included (Table 1, see also Sup-
plementary material or26 for the inclusion criteria for each study).
Healthy non-demented study participants at least 55 years old at first
measurement occasion with both memory and hippocampus mea-
surements available (“baseline” in what follows) and with at least two
memory and hippocampus measurements at least 2 years apart were
included. For individuals with several follow-up measures available,
the first measurement after a minimum of 2 years from baseline was
considered as a follow-up. In total, data on longitudinal annual changes
in hippocampal volume and episodic memory were available for 748
individuals. Data on change over multiple (ie, more than two) assess-
ments of memory and hippocampus volume involved 214 participants
(841 observations) from the Barcelona and Oslo cohorts. For these
individuals, the follow-up timewas up to 11 years (for descriptive data,
see Supplementary Table 1; for number of subjects per number of
available measurements, see Supplementary Table 2).
TABLE 1 Sample characteristics
Study
Unique
participants
Mean
baseline
age
(range)
Sex
(%female
/%male)
Mean baseline
MMSE
(range)/not
available
Mean years of
education
(range)/not
available
APOE 4
(carrier/non-
carrier/APOE
status not
available)
Mean
follow-up
interval
(range)
Barcelona/WAHA 40 68.92 (64,76) 68/32 29 (25,30)/0 10.8 (2,18)/0 7/33/0 3.28 (2,5)
Berlin/Base II 166 69.95 (61,80) 40/60 28.5 (22,30)/11 14.2 (7,18)/12 40/125/1 2.54 (2,3)
Oslo/CERAD 87 73.53 (64,90) 55/45 29.2 (25,30)/0 15 (7,23)/13 34/40/13 3.88 (2,6)
Oslo/CVLT 203 67.67 (55,85) 57/43 29 (26,30)/0 15.8 (8,22)/2 30/85/88 3.44 (2,9)
Umeå/Betula 138 64.35 (55,80) 46/54 28.1 (24,30)/0 13.3 (6,26) 34/99/5 4.74 (4,5)
Umeå/ COBRA 114 66.17 (64,68) 46/54 29.3 (27, 30)/0 13.3 (7,25) 28/85/1 5 (5,5)
Total 748 68.08 (55,90) 50/50 28.8 (22,30)/11 14.2 (2, 26)/27 173/467/108 3.76 (2,9)
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2.2 Assessments of episodic memory
Each of the participating studies contributed with one or several mea-
sures of episodic memory. Table 2 summarizes the tasks used in each
study, and Supplementary Figure 1 illustrates the distribution of indi-
vidual tests at baseline. To define an episodic-memory score for each
study, we scaled scores for each individual test by mean and standard
deviation of the respective test at study baseline. Then we used the
mean of scaled test scores as an episodic memory score at each mea-
surement occasion. Note that scaling was performed by study because
of the different scales of tests across data sets, but study was added as
a covariate in the analyses.
2.3 Magnetic resonance imaging acquisition
and analysis
Lifebrain MRI data originated from six different scanners (Table 3),
processed with FreeSurfer 6.0 (https://surfer.nmr.mgh.harvard.edu/),
generating hippocampal and intracranial volume estimates. Because
FreeSurfer is almost fully automated, to avoid introducing possible
study-specific biases, grossquality controlmeasureswere imposedand
no manual editing was done. To assess the influence of scanner on hip-
pocampal volume estimates, seven participantswere scanned on seven
different Lifebrain scanners.26 As reported in,26 there was a significant
main effect of scanner on hippocampal volume (F = 4.13 [2.1, 30], P =
.046) in this sample. However, the between-participant rank order was
almost perfectly retained between scanners. In addition, a mean of
pairwise Pearson correlations between bilateral hippocampal volumes
measured by different scanners was r= 0.98 (range 0.94 to 1.00).
2.4 Statistical analyses
Analyses were run in R 3.4.4,27 and the code for the analyses is pro-
vided in the Supplementarymaterial.
We considered a linear change of episodicmemory andbilateral hip-
pocampus volume. The linear change was estimated for each partici-
pant individually as the ordinary least squares slope estimate in the lin-
ear regression of memory score (or hippocampus volume) against the
participant’s age.
Measurements only at two occasions were available for 71% of the
subjects in the sample. Therefore, we provide analyses of two esti-
mates of linear change.
First, to be consistent in the number of measurements used in esti-
mation, we estimated the linear change using two measurements for
eachparticipant.Note that in this case, the ordinary least squares slope
is equal to the annual change, calculated as
(Xfollow−up,i − Xbaseline,i)∕(follow−up agei − baseline agei),
where Xbaseline, i is the memory score or hippocampus volume at the
baseline for subject i, and Xfollow−up, i is the value of the respectivemea-
RESEARCH INCONTEXT
1. Systematic review: Previous studies have shown that the
apolipoprotein E (APOE) ε4 allele confers elevated risk
for Alzheimer’s disease (AD), accelerated cognitive aging,
and hippocampal atrophy. Thiswork is properly cited. The
influence of APOE ε4 on the association between hip-
pocampal atrophy and episodic-memory decline in non-
demented individuals remains unclear.
2. Interpretation: Our finding of a differential longitudinal
change-change association for hippocampus andmemory
in APOE ε4 carriers compared to non-carriers supports a
model in which genetic factors modulate the translation
of the AD-related pathophysiological cascade into mem-
ory deficits.
3. Future directions: We propose validation of our findings
in forthcoming multi-wave longitudinal studies of brain-
cognition relations, combinedwith appropriate statistical
methods for analyzing longitudinal data. Future investiga-
tions can specify the exact mechanisms that foster differ-
ences in hippocampus-memory relations between APOE
ε4 carriers and non-carriers.
sure at the follow-up. We refer to such estimates of linear changes
using twomeasurements as “annual changes” further in the text.
Second, a subsample of participants from the Oslo and Barcelona
cohorts had more than two repeated measurements available (see
Supplementary Table 2 for a number of participants by the amount
of repeated measures). Therefore, in the second analysis, for these
subjects, the second measure of the linear change was defined as the
ordinary least squares slope estimated using all available repeated
observations. In what follows, we refer to such estimators of linear
changes as “slopes.”
For description of the relation between the longitudinal observa-
tions and age, we used the linearmixed-effect model with a linear term
for age and a random intercept for each subject and generalized addi-
tive mixed model (GAMM,28 using gamm4 R package29) with a semi-
parametric term for age and a random intercept for each subject.26
Akaike information criterion, bayesian information criterion, and likeli-
hood ratio testswere used to compare theGAMMand the linearmixed
effect model fit to the observed data (see Supplementary materials for
details on fitting and R code).
Next, we used partial correlations adjusted for age at baseline, sex,
and study to test the significance of hippocampus-memory change-
change associations. Study was included as a covariate in the analyses
to adjust for the differences in cognitive assessments between the
included studies. In addition, since for five of six included studies
magnetic resonance imaging (MRI) data were obtained with the same
scanner within a study, adjustment for study also captures possible
differences in MRI-derived measures due to scanner differences.
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TABLE 2 Memory assessments
Study Episodic memory tasks
Source for test
description/
dataset
Barcelona/WAHA Rey Auditory Verbal Learning
total score, Rey Auditory
Verbal Learning Test
delayed recall, Rey
Complex Figure Test
Rajaram et al.,
201718
Vaqué-Alcázar
et al., 202025
Berlin/Base II Verbal Learning andMemory
Test (combined immediate
and delayed recall), Scene
Encoding task (2.5 h
delayed recall),
Face–Profession task (3
min delayed recall), Object
Location task (immediate
recall)
Bertram et al.,
201419
Gerstorf et al.,
201650
Oslo/CERAD Consortium to Establish a
Registry for Alzheimer’s
Disease (CERAD) 10-min
delayed recall task
Fjell et al., 201820
Oslo/CVLT California learning Verbal
test, California learning
Verbal test 5-min free
recall, California learning
Verbal test 30min free
recall
Langnes et al.,
202023
Umeå/Betula Immediate recall of
sentences, Delayed cued
recall of words, Immediate
recall of words
Nilsson et al.,
199721
Umeå/COBRA Word recall, Number recall,
Object-position recall (all
immediate recall)
Nevalainen et al.,
201522
Additional adjustment for the two scanners used in Oslo cohort did
not change our main conclusion of differential memory-hippocampus
change-change relation between carriers and non-carriers.
Confidence intervals (CIs) for partial correlations were calculated
using the Fisher z-transformation and the 5% significance level.
To compare the relationship between hippocampus and episodic
memory changes for APOE ε4 carriers and non-carriers, we ran linear
regression of memory changes on hippocampus changes, age, study,
sex, an indicator of being an APOE ε4 carrier, and the interaction term
between hippocampus change, and the indicator of being an APOE
ε4 carrier. We used the significance of an interaction term in the lin-
ear regression to test if the relationship between hippocampus and
episodic memory linear changes in APOE ε4 carriers is significantly dif-
ferent from the relationship in non-carriers.
2.5 APOE ε4 status
APOE allele ε4 carriership was defined as APOE alleles ε2/ε4, ε3/ε4,
or ε4/ε4. For details on genotyping methods, see the study-specific
details.18–25
TABLE 3 MRI acquisition parameters
Study Scanner Tesla Sequence parameters
Barcelona/WAHA Tim Trio
Siemens
3.0 TR: 2300ms, TE: 2.98ms,
TI: 900ms, flip angle:
9◦ , slice thickness 1
mm, FoV 256× 256
mm, 240 slices
Berlin/Base II Tim Trio
Siemens
3.0 TR: 2500ms, TE: 4.77ms,
TI: 1100ms, flip angle:
7◦ , slice thickness: 1
mm, FoV 256× 256
mm, 176 slices
Oslo/CERAD Avanto
Siemens
1.5 TR: 2400ms, TE: 3.79ms,
TI: 1000ms, flip angle:
8◦ , slice thickness: 1.2
mm, FoV: 240× 240
mm, 160 slices
Oslo/CVLT Avanto
Siemens
1.5 TR: 2400ms, TE: 3.61ms,
TI: 1000ms, flip angle:
8◦ , slice thickness: 1.2
mm, FoV: 240× 240
mm, 160 slices, iPat= 2
Skyra Siemens 3.0 TR: 2300ms, TE: 2.98ms,
TI: 850ms, flip angle:
8◦ , slice thickness: 1
mm, FoV: 256× 256
mm, 176 slices
Umeå/Betula Discovery GE 3.0 TR: 8.2ms, TE: 3.2 ms, TI:
450ms, flip angle: 12◦ ,
slice thickness: 1 mm,
FoV 250× 250mm,
176 slices
Umeå/COBRA Discovery GE 3.0 TR: 8.2ms, TE: 3.2ms, TI:
450ms, flip angle: 12◦ ,
slice thickness: 1mm,
FoV 250× 250mm,
176 slices.
FoV, field of view; iPat, in-plane acceleration; TE, echo time; TI, inversion
time; TR, repetition time.
2.6 Data availability
The data supporting the results of the current study may be made
available on reasonable request, given appropriate ethical and data
protection approvals. Requests for data included in the analyses
can be submitted to the relevant principal investigators of each
study.
3 RESULTS
3.1 Overall results
Figure 1 shows that there was a general pattern of decline with
increasing age for episodic-memory performance as well as for
hippocampus volume, with marked individual differences (see also
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F IGURE 1 Individual trajectories for memory and hippocampal change (based on all longitudinal observations). The bold gray line indicates
mean change, estimated using a generalized additive mixedmodel.28 See Supplementarymaterial for details
F IGURE 2 Scatterplots of the residuals from the linear regression of hippocampus annual change and episodic memory annual change on
baseline age, sex, and study. Blue line—linear regression fit to the data on the scatterplots, gray area represents confidence interval. (A) Scatterplot
for all subjects in the sample. (B) Scatterplot for APOE ε4 carriers. (C) Scatterplot for non-carriers of APOE ε4. For B and C, the respective
subsamples were used in calculation of the residuals
Supplementary Table 3). Semiparametric GAMMs28 fit to the data
suggested a significant relation of age to both hippocampus and
memory, and a non-linear trend for hippocampus volume (see Supple-
mentary material for details and additional Supplementary Figure 2
for the relation of baseline measures and annual changes to baseline
age).
In the total sample (N = 748), we found a statistically signifi-
cant association between linear changes in hippocampus and memory
estimated using two observations for each subject (see Figure 2A);
partial correlation between the annual changes, adjusted for baseline
age, sex, and study is r = 0.093, P = .011, 95% CI (0.02, 0.16). For the
subsample with multiple assessments (N = 214), the annual change-
change association was r = 0.144, P = .037, CI (0.01, 0.27). When
linear changes were estimated by slopes using all available longitudi-
nal observations, the association of linear changes was estimated at
r= 0.219, P= .001, CI (0.09, 0.34).
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TABLE 4 Descriptive statistics for APOE ε4 carriers and non-carriers
APOE ε4
status N
Mean
baseline
age
(range)
% Female
/male
Mean
education
(range)
Mean
follow-up
interval
(range)
Mean
memory,
baseline
(range)
Mean
memory,
follow-up
(range)
Mean
memory
annual change
(range)
Mean hip-
pocampus
volume,
baseline
Mean hip-
pocampus
volume,
follow-up
Mean hip-
pocampus
annual
change
(range)
Carriers 173 68.44
(55, 90)
51/49 14.3 (2,
26)
3.86 (2, 6) −0.003
(−2, 2)
0 (−3, 2) 0.003 (−1, 1) 7498 (5635,
9887)
7270 (5291,
9548)
−65.11
(−379,
85)
Non-
carriers
467 68.08
(55, 88)
51/49 13.9 (4.
26)
3.77 (2, 6) 0.006 (−3,
3)
0.05 (−3,
3)
0.027 (0, 1) 7600 (4922,
9943)
7430 (4450,
10026)
−48.55
(−299,72)
Group dif-
ference
t= 0.7, df
= 291,
p-v.=
0.49
χ2 = 0.0,
df= 1,
p-val.=
1
t= 1.3,
df=
318, p-v.
= 0.19
t= 0.9,
df=
321, p-v.
= 0.37
t=−0.14,
df=
318, p-v.
= 0.9
t=−0.71,
df=
318, p-v.
= 0.48
t=−1.34, df=
333, p-v.=
0.18
t=−1.42, df
= 296, p-v.
= 0.16
t=−2.1, df
= 289, p-v.
= 0.04
t=−2.74, df
= 250, p-v.
= 0.007
3.2 Influence of APOE ε4 on
hippocampus-memory annual-change relations
Of 640 individuals withAPOE genotyping available (Table 4), 27%were
considered as carriers. This proportion varied between 17.5% and 46%
across the included studies (Table 1). When stratifying the sample into
APOE ε4 carriers (N = 173) and non-carriers (N = 467), the baseline
age, sex, and education distributions were similar between subgroups
(Table 4). In addition, the mean follow-up time, memory performances
at baseline and follow-up, and hippocampus volume at baseline were
comparable. The only significant group difference was observed at
follow-up, with a significantly smaller hippocampus volume for APOE
ε4 carriers compared to non-carriers (Table 4).
Consistent with our main prediction, the association between
annual changes in hippocampus volumeandmemory (both adjusted for
baseline age, sex, and study) was significant for carriers (Figure 2B; r
= 0.21, P = .007, CI (0.06, 0.35)) but not for non-carriers (Figure 2C;
r = 0.073, P = .117, CI (−0.02, 0.16)). Hippocampus atrophy explained
about 4% of the heterogeneity in episodic memory decline for carriers
not accounted for by age, sex, or study (partial R2 = 0.044), but <1%
for non-carriers (partial R2 = 0.005). The linear relationship between
memory and hippocampal annual change was significantly steeper for
APOE ε4 carriers compared to non-carriers (the parameter for the
interaction term was estimated as b = 0.0006, t = 2.4, df = 629, P =
.013, two-sided).
3.3 Influence of APOE ε4 on
hippocampus-memory slope relations
For the slope calculations, APOE data were available for 172 of the
214 participants with multiple (>2) assessments. The hippocampus-
memory slope relationship was r = 0.36 for 51 carriers (adjusted for
baseline age, sex, study, P = .013, CI (0.09, 0.59)), and r = 0.22 for
121 non-carriers (P = .018, CI (0.04, 0.38)). The hippocampus slope
explained 13% of the heterogeneity in episodic memory decline not
accounted for by age, sex, or study for carriers (R2 = 0.13), and 5% for
non-carriers (R2 = 0.05). The relationship between memory and hip-
pocampal slopes was again steeper for carriers than non-carriers, but
the difference was not significant (the parameter for the interaction
term was estimated as b = 0.0005, t = 0.893, df = 164, P = .37, two-
sided; z= 0.86, P= .2, one-sided). The effect size differencewas almost
identical to the one found in the annual change relations, but the sam-
ple size was smaller in this analyses of individuals withmultiple assess-
ments.
4 DISCUSSION
The pooled results across the participating Lifebrain sites confirmed
a relation of increasing age with hippocampus volume as well as
episodic-memory performance, along with marked individual differ-
ences. We found that age-related longitudinal decline in episodic
memory had a weak but significant positive relation to hippocampus
atrophy in the total sample, comprising 748 non-demented individuals.
When the samplewas stratified intoAPOE ε4 carriers and non-carriers,
the annual change-change association was significant for carriers only,
and the linear relation was significantly steeper for carriers compared
to non-carriers.
The finding of a robust hippocampus-episodic memory change-
change relationship for non-dementedAPOE ε4 carriers extends obser-
vations in previous studies of patients with dementia.6,30 The results
from a study of aged APOE ε4 knock-in mice might offer a potential
mechanism for the observed differential structure-function relation.31
Structurally, APOE ε4 will augment loss of γ-aminobutyric acid
(GABA)ergic interneurons in the hippocampal dentate gyrus, which
functionally will disrupt slow gamma oscillations during hippocampal
sharp-wave ripples and thereby contribute to impaired learning and
memory. By this view, with the caveat that our MRI data remain silent
about neuron-type and subfield-specific changes, APOE ε4 could be
a common mechanism for hippocampus structure and hippocampus-
dependent functions such as episodic memory, which translates into
a hippocampus-episodic memory change-change relation for APOE
ε4 carriers. We caution that the group difference in relationship was
GORBACH ET AL. 7 of 9
modest in size, so the underlying mechanisms might not be APOE-
genotype specific but rather amplified in ε4 carriers. Additional factors
could also contribute to this selective effect, including breakdown of
the blood-brain barrier in the hippocampus, which in a recent paper
predicted future cognitive decline in APOE ε4 carriers but not in
non-carriers.32
The weaker structure-function relationship in non-carriers is likely
driven by substantial phenotype-relevant heterogeneity. That is,
although hippocampus atrophy to some degree may contribute to
memory decline in many older individuals, it is likely that other neu-
robiological changes can be more influential for certain individuals for
whom hippocampus atrophy instead can be quite modest. This inter-
pretation resonates with previous multi-factor frameworks of cogni-
tive aging,33,34 and calls for multivariate analytic approaches that can
handle sample heterogeneity in the brain-behavior mapping.35,36 For
example, Lövdén et al.35 applied latent-profile analysis to dopamineD2
measures from cortex, hippocampus, and the striatum, and to cognitive
data frommeasures of episodicmemory, workingmemory, and percep-
tual speed. For themajority of the sample, greater receptor availability
was associated with better cognition. However, for a subgroup of indi-
viduals, high striatal dopamine related to poor working-memory per-
formance. Such sample heterogeneity reduces the strength of overall
structure-function relations.
Relatedly, although hippocampus/brain maintenance is the
strongest predictor of preserved episodic memory in aging,37,38
factors like reserve and compensation might enable relatively intact
performance possible despite marked brain changes.39,40 By this view,
some individuals with hippocampus atrophy can attain relatively good
memory performance by means of effectively recruiting extrahip-
pocampal brain networks. In non-demented aging, elevated hippocam-
pal resting-state functional connectivity has been demonstrated,41,42
and the older individuals with the highest hippocampal resting-state
connectivity had less extensive hippocampus-cortical connectivity
during memory encoding.41 Elevated hippocampal resting-state
functional connectivity has also been observed in ε4 carriers,43 which
thus could reduce the effectiveness of hippocampus-cortical net-
work interactions during cognitive tasks and weaken compensatory
processes. Conversely, based on more intact hippocampus-cortical
connectivity, APOE ε4 non-carriers might be more apt at engaging
in compensatory processes, which then would contribute toward
blurring the hippocampus-memory relation in non-carriers.
The generally stronger change-change associations from slope
estimations based on multiple measures over longer period of time,
compared with two-time point change estimates, is predicted by past
measurement theoretical work.44 With the accumulation of multi-
wave longitudinal studies of brain-cognition relations, combined with
appropriate statistical methods for analyzing longitudinal data,44,45
future analyses will likely reveal stronger change-change relations
than in the present two-wave analyses (r = 0.093) and in past cross-
sectionalmeta-analyses (r=0.097;46). Critically, future change-change
relations are still expected to be higher for ε4 carriers, as indicated by
the coherent APOE patterns for annual change as well as slope in this
study.
To obtain a reasonable sample size and by inference a sample rep-
resentative of a wider population, we pooled data across multiple
sites in the Lifebrain consortium. Similar approaches have been used
elsewhere,47,48 but we acknowledge that the use of different scanners
andmemory tasks is a limitation of the study that could have impacted
the strength and consistency of the observed associations. However,
we seeno reason that this factor should have affected carriers andnon-
carriers in different ways. Another limitation is that different proce-
dures were used to assess the clinical status of the participants across
sites. We therefore caution that our classification of participants as
non-demented should be regarded as tentative. Still, the averageMini-
Mental State Exam (MMSE) score at baseline across the entire sam-
ple of 748 individuals was close to 29, and in the five studies where
MMSEdatawereavailable at follow-uponly two individuals hada score
below24, which taken together is indicative that the sample as awhole
remained non-demented at follow-up.Moreover, we note thatmany of
the participants have or will be followed-up yet again within the spe-
cific sites. We note that the bigger change in hippocampus volume in
ε4 carriers could have influenced the chance to observe correlations
with memory change, but we view the larger negative change among
carriers as part of the phenomenon under study. Finally, the Lifebrain
database does not include measures of amyloid beta (Aβ) or tau, which
preventedus fromaddressingpossiblemechanistic roles ofAβand tau6
for the difference in hippocampus-memory relation between ε4 car-
riers and non-carriers, and the sample was biased toward older age,
which prevented us from evaluating whether the observed associa-
tions were age invariant.
5 CONCLUSION
In conclusion, a fundamental clinical and preclinical question concerns
how various pathophysiological brain changes, such as hippocampal
atrophy, translate into cognitive impairment in different individuals.
The present findings provide support for the hypothesis that carriage
of vital genetic risk alleles increases the risk for cognitive impairment.7
With the emerging trend of large-scale databases and advances in
machine learning,49 we foresee that future studies will allow better
characterization of brain-behavior relations at the individual level that
will constitute an important step toward precisionmedicine.
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